Axsome Therapeutics, Inc. (AXSM) Income Quarterly - Discounting Cash Flows
AXSM
Axsome Therapeutics, Inc.
AXSM (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025 (Q4)
12-31
2025 (Q3)
09-30
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
2014 (Q4)
12-31
2014 (Q3)
09-30
2014 (Q2)
06-30
2014 (Q1)
03-31
Report Filing 2026-02-23 2026-02-23 2025-11-03 2025-08-04 2025-05-05 2025-02-18 2024-11-12
1234
Revenue 638.5 196 171 150 121.5 118.8 104.8
1234
Cost of Revenue 47.48 12.33 11.91 13.45 9.79 10.51 8.44
1234
Gross Profit 591 183.7 159.1 136.6 111.7 108.3 96.33
1234
Operating Expenses 760.3 213.1 205.2 173.3 168.7 180.9 158.9
1234
Research & Development 183.3 48.79 40.16 49.54 44.78 55.01 45.39
1234
Selling, General and Administrative 570.6 169.3 150.2 130.3 120.8 113.3 95.56
1234
Other Operating Expenses 6.38 -4.99 14.79 -6.51 3.08 12.59 18
1234
Operating Income -169.2 -29.43 -46.11 -36.71 -56.98 -72.62 -62.62
1234
Net Non-Operating Interest -4.52 0.865 -1.12 -1.83 -2.43 -2.21 -1.98
1234
Interest Income 2.04 2.04 0 0 0 0 0
1234
Interest Expense 6.56 1.17 1.12 1.83 2.43 2.21 1.98
1234
Equity & Other Income/(Expense) -9.95 0.436 0 -10.38 0 0 0
1234
Income Before Tax -183.7 -28.13 -47.23 -48.93 -59.41 -74.83 -64.6
1234
Income Tax Expense -0.53 0.43 0 -0.96 0 0.085 0
1234
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0
1234
Net Income -183.2 -28.56 -47.23 -47.97 -59.41 -74.91 -64.6
1234
Depreciation and Amortization 8.38 2.27 1.73 2.25 2.13 2.07 2.06
1234
EBITDA -160.9 -27.16 -44.38 -34.47 -54.85 -70.54 -60.56
1234
Earnings Per Share (EPS) -3.69 -0.56 -0.94 -0.97 -1.22 -1.54 -1.34
1234
Diluted Earnings Per Share -3.69 -0.56 -0.94 -0.97 -1.22 -1.54 -1.34
1234
Weighted Average Shares Outstanding 50.63 50.63 50.02 49.44 48.87 48.54 48.14
1234
Diluted Weighted Average Shares Outstanding 50.63 50.63 50.02 49.44 48.87 48.54 48.14
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program